Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19


PDF - Export to EndNote - PubMed Central XML format - PubMed Central XML format - PubMed Central XML format
PMID: 33014319 (PubMed) - PMCID: PMC7502165 - View online: PubReader
Volume 12, Issue 4, October-December , Page 255 to 256
Monday, April 27, 2020 :Received , Monday, June 15, 2020 :Accepted



  • - Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
    - Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran

  • - Department of Biology, Science and Research branch, Islamic Azad University, Tehran, Iran
  • Corresponding author Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran, E-mail: Fdashtestani@ut.ac.ir

 

 

 



<p>Figure 1. Schematic structure of polymeric nanosystem platform for antiviral combination therapy of COVID-19.</p>

Figure 1. Schematic structure of polymeric nanosystem platform for antiviral combination therapy of COVID-19.






References :
  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.
  2. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579(7798):265-269.   [PubMed]
  3. Habibzadeh P, Stoneman EK. The novel coronavirus: A bird’s eye view. Int J Occup Environ Med 2020;11(2):65-71.   [PubMed]
  4. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive CareMed 2020;46(4):586-590.   [PubMed]
  5. Huang L, Sexton DJ, Skogerson K, Devlin M, Smith R, Sanyal I, et al. Novel peptides inhibitors of angiotensin converting enzyme 2. J Biol Chem 2003;278(18):15532-15540.   [PubMed]
  6. Koren G, King S, Knowles S, Phillips E. Ribavirin in the treatment of SARS: A new trick for an old drug? CMAJ. 2003;168(10):1289-1292.   [PubMed]
  7. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med 2005;11(8):875-879.   [PubMed]
  8. Gao Y, Kraft JC, Yu D, Ho RJ. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy. Eur J Pharm Biopharm 2019;138:75-91.   [PubMed]
  9. Zarei-Ghobadi M, Mozhgani SH, Dashtestani F, Yadegari A, Hakimian F, Norouzi M, et al. A genosensor for detection of HTLV-I based on photoluminescence quenching of fluorescent carbon dots in presence of iron magnetic nanoparticle-capped Au. Scientific Reports 2018;8(1):1-8.
  10. Zhu B, Liu GL, Ling F, Wang GX. Carbon nanotube-based nanocarrier loaded with ribavirin against grass carp reovirus. Antiviral Res 2015;118:29-38.   []
  11. Cojocaru FD, Botezat D, Gardikiotis I, Uritu CM, Dodi G, Trandafir L, et al. Nanomaterials designed for antiviral drug delivery transport across biological barriers. Pharmaceutics 2020;12(2):171.   [PubMed]
  12. Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. PT 2017;42(12):742-755.   [PubMed]
  13. Pedersen KB, Sriramula S, Chhabra KH, Xia H, Lazartigues E. Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays. Am J Physiol Regul Integr Comp Physiol 2011;301(5):R1293-1299.   [PubMed]
  14. Locatelli E, Comes Franchini M. Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system. J Nanopart Res 2012;14(12):1316.

Home | About us | Contact us | Search | Site Map | Feeds | Rights & Permissions

"Avicenna Journal of Medical Biotechnology - A.J.M.B." is owned, published, and copyrighted by © 2020 Avicenna Research Institute. (pISSN: 2008-2835 .::. eISSN: 2008-4625)

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Creative Commons License